Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/1132
Title: Variations of surveillance practice for patients with bone sarcoma: a survey of Australian sarcoma clinicians.
Epworth Authors: Bae, Susan
Desai, Jayesh
Other Authors: Lewin, Jeremy
Thompson, Kate
Strong, Robyn
Caruso, Denise
Howell, Deborah
Herschtal, Alan
Sullivan, Michael
Orme, Lisa
Keywords: Neoplasms
Cancer
Bone Sarcoma
Multimodal Therapy
Pediatric Medical Oncology
PO
Nonpediatric Medical Oncology
NP
Paediatric Medical Oncology
Nonpaediatric Medical Oncology
Relapse
Surveillance Practice
Radiologic Surveillance Strategies
RS
Late Toxicity Assessment
Psychosocial Interventions
Local Disease
Metastatic Disease
Cancer Services Clinical Institute, Epworth HealthCare, Victoria, Australia
Issue Date: 2017
Publisher: Hindawi
Citation: Sarcoma. 2017;2017:1837475
Abstract: INTRODUCTION: After treatment, bone sarcoma patients carry a high chance of relapse and late effects from multimodal therapy. We hypothesize that significant variation in surveillance practice exists between pediatric medical oncology (PO) and nonpediatric medical oncology (NP) sarcoma disciplines. METHODS Australian sarcoma clinicians were approached to do a web based survey that assessed radiologic surveillance (RS) strategies, late toxicity assessment, and posttreatment psychosocial interventions. RESULTS: In total, 51 clinicians responded. No differences were identified in local disease RS. In metastatic disease response assessment, 100% of POs (23/23) and 93% of NPs (24/26) conducted CT chest. However, this was more likely to occur for NPs in the context of a CT chest/abdomen/pelvis (NP: 10/26; PO: 1/23; p = 0.006). POs were more likely to use CXR for RS (p = 0.006). POs showed more prescriptive intensity in assessment of heart function (p = 0.001), hearing (p < 0.001), and fertility (p = 0.02). POs were more likely to deliver written information for health maintenance/treatment summary (p = 0.04). The majority of respondents described enquiring about psychosocial aspects of health (n = 33/37, 89%), but a routine formal psychosocial screen was only used by 23% (n = 6/26). CONCLUSION: There is high variability in bone sarcoma surveillance between PO and NP clinicians. Efforts to harmonize approaches would allow early and late effects recognition/intervention and facilitate improved patient care/transition and research.
URI: http://hdl.handle.net/11434/1132
DOI: 10.1155/2017/1837475
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350324/pdf/SARCOMA2017-1837475.pdf
PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/28348507
ISSN: 1357-714X
1369-1643
Journal Title: Sarcoma
Type: Journal Article
Affiliated Organisations: Victorian Adolescent & Young Adult Cancer Service, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Adolescent and Young Adult Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Australasian Sarcoma Study Group, Melbourne, VIC, Australia.
Australian and New Zealand Children's Hematology/Oncology Group, Melbourne, VIC, Australia.
Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Children's Cancer Centre, Royal Children's Hospital, Melbourne, VIC, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.
Type of Clinical Study or Trial: Cross-Sectional Study
Appears in Collections:Cancer Services

Files in This Item:
File Description SizeFormat 
Bae.pdf746.04 kBAdobe PDFView/Open


Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.